We examined the genetic status of human leucocyte antigens (HLA), human platelet alloantigens (HPA) and neutrophil‐specific antigens (NA) in patients with type 2 diabetes mellitus and diabetic arteriosclerosis obliterans (ASO). To our knowledge, the present study is the first report showing the relationship among three genetic factors in type 2 diabetes mellitus and ASO patients. HLA typing was performed by the polymerase chain reaction (PCR)–restriction fragment length polymorphism method. HPA‐typing and NA‐typing were by a PCR‐sequence‐specific primer method. The incidence of HLA‐DRB1*1501 was found to be significant in type 2 diabetes and non‐diabetic, particularly ASO‐positive patients, compared to control subjects. There were no differences in NA1/NA2 between the control and diabetic or non‐diabetic ASO groups. However, the frequency of NA2/NA2 in ASO‐positive diabetes and non‐diabetic ASO patients was significantly higher than controls. The a/b genotype of HPA‐5a/5b was significantly lower in type 2 diabetes and non‐diabetic ASO‐positive patients than in controls. These findings suggest that genetic studies of HLA, NA and HPA could be useful to understand the pathogenesis of type 2 diabetes and ASO.
Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASO
S. Nomura,A. Shouzu,S. Omoto,T. Matsuzaki,M. Yamaoka,Misao Abe,M. Hosokawa,M. Nishikawa,T. Iwasaka,S. Fukuhara
Published 2006 in International Journal of Immunogenetics
ABSTRACT
PUBLICATION RECORD
- Publication year
2006
- Venue
International Journal of Immunogenetics
- Publication date
2006-04-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-69 of 69 references · Page 1 of 1
CITED BY
Showing 1-11 of 11 citing papers · Page 1 of 1